THE WIRE · № 70862
Shoulder Innovations Initiates Commercial Launch of the InSet® Go
01 THE MACHINE READ
WHY IT MATTERS.
Shoulder Innovations begins limited launch of a next-gen glenoid implant; early commercial step for a small medtech with no financials.
Early-stage medtech launch, unproven scale
Broader commercial release
Limited release may not convert to sales
FULL DISPATCH
Limited User Release of the Company's Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case GRAND RAPIDS, Mich., Oct. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality2026-10-08 11:03 UTC
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy2026-10-08 11:30 UTC
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology2026-10-08 11:30 UTC
Aragen Life Sciences begins Operations at OneHP, an Integrated High-potency Platform in Hyderabad, India2026-10-08 11:30 UTC
Keenova Announces New Presentations at the Sexual Medicine Society of North America Annual Meeting2026-10-08 11:30 UTC
Saol Therapeutics Announces Completion of Enrollment in Pivotal Phase III BEACON Trial of SL1002 for the Treatment of Chronic Pain Related to Osteoarthritis of the Knee2026-10-08 11:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.